Gilead Sciences Inc - Company Profile

Powered by

All the data and insights you need on Gilead Sciences Inc in one report.

  • Save hours of research time and resources with
    our up-to-date Gilead Sciences Inc Strategy Report

  • Understand Gilead Sciences Inc position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Gilead Sciences Inc (Gilead) is a research-based biopharmaceutical company. It is engaged in the discovery, development and commercialization of medicines for the treatment of cardiovascular, hematological and respiratory diseases, inflammation, liver diseases, cancer, and human immunodeficiency virus (HIV) infection. The company sells its products through subsidiaries and distributors in Europe, the Americas, Asia-Pacific, the Middle East and Africa. It has manufacturing facilities in Edmonton, Alberta, Canada; Foster City, San Dimas, Oceanside, California; and Cork, Ireland among others. The company has partnerships with universities, medical research institutions and global pharmaceutical leaders to develop new drugs. Gilead is headquartered in Foster City, California, the US.

Gain a 360-degree view of Gilead Sciences Inc and make more informed decisions for your business Gain a 360-degree view of Gilead Sciences Inc and make more informed decisions for your business Find out more
Headquarters United States of America

Address 333 Lakeside Dr, Foster City, California, 94404


Telephone 1 650 5743000

No of Employees 17,000

Industry Pharmaceuticals and Healthcare

Ticker Symbol & Exchange GILD (NASD)

Revenue (2023) $27.1B -0.6% (2023 vs 2022)

EPS XYZ

Net Income (2023) XYZ 23.3% (2023 vs 2022)

Market Cap* $89.8B

Net Profit Margin (2023) XYZ 24.1% (2023 vs 2022)

* As of and is in US$
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

Gilead Sciences Inc premium industry data and analytics

1,500+

Clinical Trials

Determine Gilead Sciences Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

740+

Catalyst Calendar

Proactively evaluate Gilead Sciences Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

690+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Gilead Sciences Inc’s relevant decision makers and contact details.

400+

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

330+

Pipeline Drugs

Identify which of Gilead Sciences Inc’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

70+

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

40+

Sales & Consensus Forecasts

Understand the current and future drug revenue for Gilead Sciences Inc and assess market opportunity for new entrants with patient population 8-year forecasts.

30+

Marketed Drugs

Understand Gilead Sciences Inc’s commercialized product portfolio to stay one step ahead of the market.

1

IT Services Contracts

Improve competitive bidding with insights into all publicly disclosed IT services contracts for Gilead Sciences Inc (including IT outsourcing, business process outsourcing, systems integration & consulting and more).

Products and Services

Products Brands
HIV/AIDS AmBisome
Atripla Atripla
Biktarvy Biktarvy
XYZ XYZ
XYZ XYZ
XYZ XYZ
Understand Gilead Sciences Inc portfolio and identify potential areas for collaboration Understand Gilead Sciences Inc portfolio and identify potential areas for collaboration Find out more

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2024 Contracts/Agreements In February, the company and Biocytogen entered into an agreement to leverage the discovery and development of new antibody therapeutics.
2024 Contracts/Agreements In February, the company entered into an agreement to acquire CymaBay Therapeutics for US$4.3 billion.
2024 Contracts/Agreements In February, the company announced a collabration with Dragonfly Therapeutics to evaluate the potential DF1001 with Trodelvy for two cancer indications.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Find out more
Image for loader

Competitor Comparison

Key Parameters Gilead Sciences Inc Merck & Co Inc Pfizer Inc Novartis AG Abbott Laboratories
Headquarters United States of America United States of America United States of America Switzerland United States of America
City Foster City Kenilworth New York Basel Abbott Park
State/Province California New Jersey New York - Illinois
No. of Employees 17,000 69,000 83,000 76,057 115,000
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Daniel P. O’Day Chief Executive Officer; Chairman Executive Board 2019 57
Andrew D. Dickinson Chief Financial Officer Senior Management 2016 52
Diane E. Wilfong Chief Accounting Officer; Senior Vice President Senior Management 2016 -
Merdad V. Parsey, M.D., Ph.D. Chief Medical Officer Senior Management 2019 59
Johanna Mercier Chief Commercial Officer Senior Management 2019 52
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into Gilead Sciences Inc key executives to enhance your sales strategy Gain insight into Gilead Sciences Inc key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward